Medications

View our COVID-19 Vaccine Toolkit

To help you prepare to administer vaccines and answer questions from your patients, view our COVID-19 Vaccines Toolkit.

Early prescription medication refills

We allow for early refills for prescription medications, except for opioids, through the federal public health emergency.

Extended day supply

We allow for a refill on medications used for chronic conditions, such as diabetes, asthma and heart disease.

Line of business

Extended supply of medications coverage

Home-delivery options

Commercial members (except for a few self-funded groups)

Allowing for a 90-day refill on medications used for chronic conditions, such as diabetes, asthma and heart disease

Members can order home-delivery prescriptions through the Express Scripts Home Delivery or 1 (833) 599-0451

Medicare Advantage members who have medical and pharmacy benefits

Allowing for a 100-day refill on medications used for chronic conditions, such as diabetes, asthma and heart disease

Members can order home-delivery prescriptions through:

Members who have a Medicare Part D prescription drug plan

Allowing for a 90-day refill on medications used for chronic conditions, such as diabetes, asthma and heart disease.

Members can order home-delivery prescriptions through:

Note: Some drugs are not eligible for extended day supply, including controlled substances and certain specialty drugs. Drugs listed on our formularies in the Narcotics and section marked SP are not eligible for an extended supply.

Therapeutic options for patients with COVID-19

View the list of drugs and non-vaccine biological products for treating COVID-19 that have received emergency use authorizations (EUAs) from the U.S. Food and Drug Administration (FDA).

The Centers for Medicare and Medicaid Services’ (CMS’) implemented 12 new International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS) procedure codes to describe infusion of therapeutics, including remdesivir and convalescent plasma, effective August 1, 2020.

In addition, CMS implemented 21 new procedure codes to describe the introduction or infusion of therapeutics, including monoclonal antibodies and vaccines for COVID-19 treatment, into the International Classification of Diseases, Tenth Revision, Procedure Coding System (ICD-10-PCS), effective January 1, 2021.

  • The ICD-10 MS-DRG V38.1 Grouper Software, Definitions Manual Table of Contents, and the Definitions of Medicare Code Edits V38.1 manual to accommodate these new diagnosis and procedure codes, effective for discharges on or after January 1, 2021 are available on CMS’ website.
  • The Index and Tabular Addenda for the new diagnosis codes is available on the CDC website.

Monoclonal antibody therapy resources:

Claims submission

  • Commercial members: Submit claims for these medications to Regence.
  • Medicare Advantage members: Submit claims for these medications to Medicare.

View all COVID-19 updates and resources